Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,415	6,669	7,738	4,819	3,819	2,959
Trading Asset Securities	5,168	5,161	3,178	3,045	1,675	1,258
Cash & Short-Term Investments	12,583	11,830	10,916	7,863	5,494	4,217
Cash Growth	-1.96%	8.37%	38.82%	43.13%	30.28%	70.40%
Accounts Receivable	1,535	2,257	2,782	2,850	2,183	2,032
Other Receivables	24.82	12.5	14.99	17.2	11.98	10.33
Receivables	1,559	2,270	2,797	2,867	2,195	2,042
Inventory	457.27	569.09	490.08	391.48	375.59	278.42
Other Current Assets	36.99	32.6	32.5	54.23	58.34	38.13
Total Current Assets	14,637	14,702	14,235	11,177	8,123	6,576
Property, Plant & Equipment	2,639	2,706	2,922	2,856	3,034	3,141
Long-Term Investments	481.92	464.71	393.97	332.34	328.44	155.33
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	301.86	308.56	305.01	320.62	280.04	283.84
Long-Term Deferred Tax Assets	34.67	41.83	45.45	62.16	57.32	42.62
Long-Term Deferred Charges	2.18	2.38	11.91	3.87	13.19	23.67
Other Long-Term Assets	69.89	66.44	62.16	62.14	127.96	126.51
Total Assets	18,333	18,459	18,144	14,981	12,131	10,516
Accounts Payable	1,569	1,730	2,141	1,505	945.77	452.52
Accrued Expenses	68.31	254.87	246.62	350.39	242.7	207.74
Short-Term Debt	692.16	836.39	1,088	400	-	-
Current Portion of Long-Term Debt	-	-	-	-	627.55	-
Current Portion of Leases	1.1	1.07	1.06	0.44	1.55	-
Current Income Taxes Payable	88.6	99.77	182.62	106.09	43.71	69.64
Current Unearned Revenue	23.7	17.92	17.25	49.14	19.34	8.03
Other Current Liabilities	523.54	598.01	915.86	1,016	919.98	1,229
Total Current Liabilities	2,967	3,538	4,592	3,427	2,801	1,967
Long-Term Debt	-	-	-	-	-	602.58
Long-Term Leases	0.74	1.04	1.43	0.2	1.02	-
Long-Term Unearned Revenue	63.93	65.45	71.43	78.19	84.63	90.67
Long-Term Deferred Tax Liabilities	134.4	127.84	109.28	122.05	112.38	90.72
Other Long-Term Liabilities	0.48	0.53	0.82	1.06	1.35	1.67
Total Liabilities	3,166	3,733	4,775	3,629	3,000	2,753
Common Stock	452.69	452.69	452.74	452.74	436.27	436.26
Additional Paid-In Capital	4,013	4,012	3,999	3,984	3,148	3,114
Retained Earnings	10,786	10,345	9,010	6,998	5,431	4,112
Treasury Stock	-110.22	-108.57	-111.97	-97.18	-	-
Comprehensive Income & Other	-	-	-	-	100.81	100.87
Total Common Equity	15,142	14,702	13,349	11,337	9,117	7,763
Minority Interest	25.53	24.57	19.42	15.14	14.17	-
Shareholders' Equity	15,167	14,726	13,369	11,352	9,131	7,763
Total Liabilities & Equity	18,333	18,459	18,144	14,981	12,131	10,516
Total Debt	694	838.5	1,090	400.65	630.12	602.58
Net Cash (Debt)	11,889	10,992	9,826	7,463	4,864	3,615
Net Cash Growth	6.73%	11.86%	31.67%	53.43%	34.56%	90.37%
Net Cash Per Share	12.97	11.98	10.72	8.22	5.40	4.33
Filing Date Shares Outstanding	917.37	912.53	921.81	921.82	888.27	888.26
Total Common Shares Outstanding	917.37	912.53	921.81	921.82	888.27	888.26
Working Capital	11,670	11,164	9,644	7,749	5,322	4,609
Book Value Per Share	16.51	16.11	14.48	12.30	10.26	8.74
Tangible Book Value	14,673	14,226	12,877	10,849	8,670	7,312
Tangible Book Value Per Share	15.99	15.59	13.97	11.77	9.76	8.23
Buildings	-	2,953	2,911	2,455	2,473	2,362
Machinery	-	1,728	1,685	1,644	1,566	1,488
Construction In Progress	-	156.63	186.98	352.15	322.17	364.89

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.